Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 0.793
-2.47 %
$ 115 M
Market Cap
-2.14
P/E
BDSX - COST OF REVENUE
Cost of Revenue BDSX - Biodesix, Inc.
13 M
LAST VALUE
-34.71%
2 YEAR CAGR
24.18%
5 YEAR CAGR
0.00%
10 YEAR CAGR